
About Aceto
Aceto is a publicly listed company based in New York (United States) founded in 1947. APIs, intermediates, formulations, and chemicals are manufactured and distributed. Aceto has completed 8 acquisitions, including A&C, A&C Bio Buffer and Biotron Laboratories. Its Indian entity Aceto Pharma (India) Private Limited reported revenue of ₹341 Cr. Aceto offers products and services including Analytical Services, GMP Contract Manufacturing, and R&D Services. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides. Its competitors include Asymchem, Aptuit and Continuus Pharma; 2 of its 3 listed competitors have raised funding.
Company details
Aceto was founded in 1947 in New York, United States, within the chemicals and pharmaceuticals sector. Marketing, sale, and distribution of human health products, pharmaceutical ingredients, and performance chemicals are handled by the company. Finished dosage form generics and nutritionals form part of human health offerings. APIs and pharmaceutical intermediates constitute the pharmaceutical ingredients. Specialty chemicals and agricultural protection products are included in performance chemicals.
- Headquarters New York, United States
- Stage Public
- SectorsHealthcare
- Website aceto.com
- Social LinkedIn YouTube
- Legal Name Aceto Pharma (India) Private Limited
- Date of Incorporation 29 Jan, 2007
- Jurisdiction Sanand, Gujarat, India
- Indian entity revenue₹341 Cr
FY 2025 · 0% YoY
- Indian entity net profit₹69.97 Cr
FY 2025 · 21% margin
- Indian entity EBITDA₹103 Cr
FY 2025 · 30% margin
- Latest Funding Round$144M (USD), Post-IPO
Nov 2015
- Investments & AcquisitionsA&C
& 7 more
Associated legal entities of Aceto
Aceto operates through Aceto Pharma (India) Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Aceto Pharma (India) Private Limited CIN U24232GJ2007FTC142338 | Active | 29 Jan 2007 | Sanand, Gujarat | ₹341 Cr | 28 | 5 | View details |
Products & Services of Aceto
Aceto offers a comprehensive portfolio of products and services, including Analytical Services, GMP Contract Manufacturing, and R&D Services.
Offers testing for raw materials in multiple industries
Provides contract production of APIs and intermediates
Delivers custom research and scale-up for ingredient solutions
Apps and channels of Aceto
its YouTube channel Actylis has 66 subscribers and 10 videos.
Videos from Aceto
The most watched videos on Aceto's YouTube channel, Actylis (66 subscribers). Click a video to play it here.
More on Actylis.
Funding Insights of Aceto
- Total Rounds 1
- Last Round Post-IPO — $144M
- First Round $144M
(Nov 2015)
All 1 funding rounds of Aceto with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2015 | $144M | Post-IPO | – | – | – |
Board of directors of Aceto Pharma (India) Private Limited (Aceto)
Aceto Pharma (India) Private Limited is the primary company behind Aceto. The board of Aceto Pharma (India) Private Limited currently have 4 directors; the longest-serving is Varun Vijay Rao, appointed in 2020. 11 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Varun Vijay Rao DIN 02509615 | Director | 02 Nov 2020 | 6 yrs | Aceto Pharma (India) Private Limited |
| Arpit Chandrakant Butala DIN 10348219 | Director | 06 Feb 2024 | 2 yrs 9 mo | Aceto Pharma (India) Private Limited |
| Raj Kumar Gupta DIN 11039904 | Additional Director | 09 Apr 2025 | 1 yr 7 mo | Aceto Pharma (India) Private Limited |
| Eric Gaertner DIN 11376375 | Additional Director | 11 Nov 2025 | 1 yr | Aceto Pharma (India) Private Limited |
People of Aceto
73 people are tracked at Aceto (33 in leadership, 4 in board & advisors, 36 in team).
| Name | Role | Group |
|---|---|---|
Rajesh Patel | Business Development Director - Cosmetic | Leadership |
Larry Fertel | Research Director | Leadership |
| Director Quality & Regulatory- APAC | Leadership | |
Amit Maheshwari | President, Finar | Leadership |
James Steele | Chief Financial Officer | Leadership |
Jean-Pierre Darriot | Head Of Finance Europe | Leadership |
Jeremiah Marsden | President, Cascade & Head of Global R&D | Leadership |
Eric Escobar | Vice President Global Pharma Sales | Leadership |
Julie Sternberg | Sales Director Strategic Accounts Pharma Europe | Leadership |
Scott Thomson | Chief Executive Officer | Leadership |
Ryan Kinkaid | Associate Director, New Business Development At Actylis | Leadership |
John Elliot Simpkins | Chief Human Resources Officer | Leadership |
Lauren Seufert | Chief Strategy Officer | Leadership |
Tim Quinn | Vice President & General Manager Pharmaceuticals | Leadership |
Kristin Decarolis | Director, Financial Reporting And Compliance | Leadership |
Prasanna H M | Head Of Fp&a, Data Office | Leadership |
Jeffrey Hatch | Associate Director, Business Development At Actylis | Leadership |
Stephanie Scroggie | Vice President / Corporate Controller | Leadership |
Penny Lipe | Vice President, Financial Planning & Analysis | Leadership |
Jessie Pannu | Director Of Quality And Regulatory Affairs | Leadership |
53 more people are available in the full profile.
Complete people profiles for Aceto
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Aceto
Aceto is a publicly listed company on the NASDAQ with ticker symbol ACET in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date13 Jan 1978
- Listed onNASDAQ: ACET
- Listed entityAdicet Bio, Inc.
- Exchange sectorHealth technology
Financials of Aceto
Figures of Aceto Pharma (India) Private Limited, the primary company behind Aceto, for FY 2025. Revenue was ₹341 Cr (0% year on year). Net profit was ₹69.97 Cr (21% margin). EBITDA was ₹103 Cr (30% margin). Revenue has grown at a compounded annual rate of +5% over three years and +117% over five years.
- ₹341 CrRevenue · FY 2025 · 0% YoY
- ₹69.97 CrNet profit · 21% margin
- ₹103 CrEBITDA · 30% margin
- ₹101 CrPaid-up capital
- 28Employees (provident fund records)
- +5%Revenue CAGR, 3 years
- +117%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Aceto Pharma (India) Private Limited are on its company page.
Detailed financial statements for Aceto
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aceto
Aceto has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include A&C, A&C Bio Buffer and Biotron Laboratories.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Mineral ingredient consulting services are provided to industry clients. | talusminerals.com | Ogden, United States | 2014 | Mar 2022 | •••• | |
Laboratory focused on developing chelated mineral products | biotronlabs.com | Centerville, United States | 1979 | Mar 2022 | •••• | |
GMP biological buffers, cleaning solutions, and related products are manufactured. | acbiobuffer.com | Limerick, Ireland | 2018 | Oct 2021 | •••• | |
Synthetic, analytical, and API manufacturing services are provided. | cascadechemistry.com | Eugene, United States | 1980 | Jun 2021 | •••• | |
Manufacturer of excipients, solvents, lab chemicals, food additives, and other fine chemicals | finarchemicals.com | Ahmedabad, India | 1998 | May 2021 | •••• | |
APIs and pharmaceutical intermediates are manufactured by A&C. | acggp.com | Montreal, Canada | 1966 | Apr 2021 | •••• | |
Chemicals for multiple sectors are manufactured through focused R&D. | islechem.com | Grand Island, United States | 2001 | Dec 2020 | •••• | |
Pharmaceutical, agrochemical, aroma, and polymer chemicals are manufactured and supplied. | syntor.co.uk | Runcorn, United Kingdom | 2004 | Apr 2020 | •••• |
Complete acquisition details for Aceto
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Aceto
11 dated milestones of Aceto across 75 years, from founding to its latest funding, stage changes and deals.
- Founded Aceto is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $144.0M.
- Acquisition Acquires Syntor.
- Acquisition Acquires IsleChem.
- Acquisition Acquires A&C.
- Acquisition Acquires Finar.
- Acquisition Acquires Cascade Chemistry.
- Acquisition Acquires A&C Bio Buffer.
- Acquisition Acquires Talus Mineral.
- Acquisition Acquires Biotron Laboratories.
Competitors of Aceto
Aceto has 3 listed competitors in our database, 2 of them funded. They include Asymchem, Aptuit and Continuus Pharma.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| asymchem.com | 1995 | Morrisville, United States | 48 | APIs and peptides are developed and manufactured by Asymchem. | ||
| aptuit.com | 2004 | Greenwich, United States | $14.23M | Contract research and development services for small molecules are offered. | ||
| continuuspharma.com | 2012 | Woburn, United States | $7.73M | 47 | MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development |
Detailed competitors of Aceto
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Aceto
Websites that share an audience with Aceto (aceto.com).
Websites whose visitors overlap most with Aceto. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
amerchem.com | amerchem.com | 100% | – | ||
matrix-marketing.ch | matrix-marketing.ch | 100% | – | ||
changje.com | changje.com | 100% | – | ||
sundry-tech.com | sundry-tech.com | 100% | – | ||
rollechim.com | rollechim.com | 84% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 30 similar websites and full traffic analytics for Aceto
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 30 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Aceto (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Aceto
Complete news archive for Aceto
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aceto
Aceto was founded in 1947 and raised its 1st funding round 68 years after it was founded.
Aceto is headquartered in New York, United States. It is registered at New York, New York, United States.
The primary company behind Aceto, Aceto Pharma (India) Private Limited, reported revenue of ₹341 Cr for FY 2025, down 0% year on year.
Aceto was founded in 1947 in New York, United States, within the chemicals and pharmaceuticals sector. Marketing, sale, and distribution of human health products, pharmaceutical ingredients, and performance chemicals are handled by the company. Finished dosage form generics and nutritionals form part of human health offerings. APIs and pharmaceutical intermediates constitute the pharmaceutical ingredients. Specialty chemicals and agricultural protection products are included in performance chemicals.
Aceto's top competitors include Asymchem, Aptuit and Continuus Pharma.
Aceto offers Analytical Services, GMP Contract Manufacturing, and R&D Services.
Yes, Aceto is publicly traded on NASDAQ under the ticker symbol ACET.
Aceto has made 8 acquisitions, including A&C, A&C Bio Buffer, and Biotron Laboratories.
Aceto operates through Aceto Pharma (India) Private Limited.
The legal entities of Aceto currently have 5 directors, including Arpit Chandrakant Butala, Varun Vijay Rao, Madhaviben Bhaskarbhai Dave and others.
